CMNDF
Clearmind Medicine Inc

33
Mkt Cap
$2.92M
Volume
23.12M
52W High
$2.18
52W Low
$0.24
PE Ratio
-0.33
CMNDF Fundamentals
Price
$0.30
Prev Close
$0.2769
Open
$0.3532
50D MA
$0.9041
Beta
0.32
Avg. Volume
737,848.22
EPS (Annual)
-$1.70
P/B
1.40
Loading...
Loading...
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.
Sector:
Non Energy Minerals
Industry:
Other Metals Or Minerals
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Clearmind Medicine Inc?
What is the 52-week high for Clearmind Medicine Inc?
What is the 52-week low for Clearmind Medicine Inc?
What is Clearmind Medicine Inc stock price today?
What was Clearmind Medicine Inc stock price yesterday?
What is the PE ratio of Clearmind Medicine Inc?
What is the Price-to-Book ratio of Clearmind Medicine Inc?
What is the 50-day moving average of Clearmind Medicine Inc?

Latest CMNDF News

View
No CMNDF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.